240 related articles for article (PubMed ID: 24359609)
21. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
Hallows JL; Chen K; DePinho RA; Vincent I
J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
[TBL] [Abstract][Full Text] [Related]
22. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of TNF reduces mechanical orofacial hyperalgesia induced by Complete Freund's Adjuvant by a TRPV1-dependent mechanism in mice.
Lis K; Grygorowicz T; Cudna A; Szymkowski DE; Bałkowiec-Iskra E
Pharmacol Rep; 2017 Dec; 69(6):1380-1385. PubMed ID: 29132095
[TBL] [Abstract][Full Text] [Related]
25. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
[TBL] [Abstract][Full Text] [Related]
26. Cdk5 contributes to inflammation-induced thermal hyperalgesia mediated by the p38 MAPK pathway in microglia.
Fang-Hu ; Zhang HH; Yang BX; Huang JL; Shun JL; Kong FJ; Peng-Xu ; Chen ZG; Lu JM
Brain Res; 2015 Sep; 1619():166-75. PubMed ID: 25819553
[TBL] [Abstract][Full Text] [Related]
27. TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells.
Utreras E; Prochazkova M; Terse A; Gross J; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2013 May; 9():24. PubMed ID: 23668392
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
29. Modulation of Reelin signaling by Cyclin-dependent kinase 5.
Ohshima T; Suzuki H; Morimura T; Ogawa M; Mikoshiba K
Brain Res; 2007 Apr; 1140():84-95. PubMed ID: 16529723
[TBL] [Abstract][Full Text] [Related]
30. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis.
Pareek TK; Lam E; Zheng X; Askew D; Kulkarni AB; Chance MR; Huang AY; Cooke KR; Letterio JJ
J Exp Med; 2010 Oct; 207(11):2507-19. PubMed ID: 20937706
[TBL] [Abstract][Full Text] [Related]
31. The BDNF/TrkB signaling pathway is involved in heat hyperalgesia mediated by Cdk5 in rats.
Zhang HH; Zhang XQ; Xue QS; Yan-Luo ; Huang JL; Zhang S; Shao HJ; Lu H; Wang WY; Yu BW
PLoS One; 2014; 9(1):e85536. PubMed ID: 24465591
[TBL] [Abstract][Full Text] [Related]
32. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
[TBL] [Abstract][Full Text] [Related]
34. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
35. VGLUT2/Cdk5/p25 Signaling Pathway Contributed to Inflammatory Pain by Complete Freund's Adjuvant.
Tang Y; Peng Z; Tao S; Sun J; Wang W; Guo X; Liu G; Luo X; Chen Y; Shen Y; Ma H; Xu P; Li Q; Zhang H; Feng Z
Pain Res Manag; 2020; 2020():4807674. PubMed ID: 32190166
[TBL] [Abstract][Full Text] [Related]
36. CGRP Induces Differential Regulation of Cytokines from Satellite Glial Cells in Trigeminal Ganglia and Orofacial Nociception.
Afroz S; Arakaki R; Iwasa T; Oshima M; Hosoki M; Inoue M; Baba O; Okayama Y; Matsuka Y
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736422
[TBL] [Abstract][Full Text] [Related]
37. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
38. The Cdk5/p35 kinases modulate leptin-induced STAT3 signaling.
He Y; Kastin AJ; Hsuchou H; Pan W
J Mol Neurosci; 2009 Sep; 39(1-2):49-58. PubMed ID: 19156541
[TBL] [Abstract][Full Text] [Related]
39. Transient enhanced expression of Cdk5 activator p25 after acute and chronic d-amphetamine administration.
Mlewski EC; Krapacher FA; Ferreras S; Paglini G
Ann N Y Acad Sci; 2008 Oct; 1139():89-102. PubMed ID: 18991853
[TBL] [Abstract][Full Text] [Related]
40. The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins.
Kanungo J; Zheng YL; Amin ND; Pant HC
J Neurochem; 2008 Sep; 106(5):2236-48. PubMed ID: 18662245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
